After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Imran Khan's difficulties will not reduce even after obtaining confidence vote
The news related to the election of the Senate and the vote of confidence of the Imran Khan gover
Amidst the ongoing controversy over Aurangzeb and the violence in Nagpur over his tomb, the RSS h
Bigg Boss 19: Who got eliminated in Weekend Ka Vaar? Kunika left captaincy!
Bigg Boss 19's first Weekend Ka Vaar is always a blast. Salman Khan teaches a lesson to the conte
South cinema superstar Thalapathy Vijay's film 'Leo' made a good collection at the ticket window.
Ireland's most successful batsman Kevin O'Brien has said goodbye to international cricket. O'Brie
The Indian government bought spy software Pegasus from the Israeli company NSO Group in 2017. Thi
A Pakistani cleric has made a highly controversial comment about Bollywood actress Aishwarya Rai.
Karnataka SSLC Result 2023 Out: Karnataka Board 10th result released, 83.89 pass percentage
KSEAB Karnataka SSLC Results in 2023 Out The Karnataka School Examination and Evaluation Board (K
Janmashtami 2023 Krishna Janmashtami is celebrated across the country today. Crowds of devotees a
Even after the change of power in Pakistan, inflation is not taking the name of decreasing. Risin
